a study showing that treatment is not always necessary for duodenal-type follicular lymphoma
Published 4 weeks ago • 48 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:24
cd30 and tumor progression in hodgkin lymphoma
-
37:15
eurobloodnet's topic on focus: cutaneous lymphoma - cd30 lymphoproliferations
-
3:20
t-cell lymphoma differential diagnosis and cd30 treatment
-
2:22
cd19 and cd20 car t-cell therapy for non-hodgkin lymphoma
-
1:21
cd20/cd3 bispecific antibodies in r/r dlbcl: glofitamab and epcoritamab
-
4:05
celmod in lymphoma treatment: phase 1/2 study insights | marc hoffman, md | eha 2024
-
2:29:21
immuno-oncology for cd30 lymphomas - mhg
-
12:21
non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology
-
10:58
non-hodgkin lymphoma - what you need to know
-
4:54
understanding diffuse large b-cell lymphoma (dlbcl)
-
1:48
first-in-class igm based cd20-cd3 bispecific antibody in b-cell nhl
-
1:49
dr. kaplan on frontline treatment options in follicular lymphoma
-
4:12
mixed cellularity hodgkin lymphoma - histopathology
-
1:25
dr. kaplan on the relevance trial in follicular lymphoma
-
8:21
diffuse large b-cell lymphoma (dlbcl) - aggressive b-cell neoplasm - non-hodgkin’s lymphoma
-
1:31
is cd30 an accurate diagnostic marker in lymphomas other than hodgkin lymphoma?
-
1:31
the standard of care in relapsed refractory cd30 lymphoma
-
0:54
the role of cd4 t-cells in the pathogenesis of hodgkin lymphoma
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
1:01
pitfalls in the diagnosis of lymphoid malignancies: interpreting pet scans
-
5:50
histopathology - nodular lymphocyte predominant hodgkin lymphoma
-
2:17
how will the treatment landscape for ctcl change in the coming years?